NSECertificate under SEBI (Depositories and Participants) Regulations, 20181 Jul 2026 · 1 Jul 2026, 04:35 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Biofil Chemicals & Pharmaceuticals Limited · BIOFILCHEM

✦ AI SummaryResults

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th June, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

BIOFILCHEM_01072026163434_Regulation7401072026.pdf

pdf

Download →
View document text
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) Tel. 0731-2426700; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2426700 To Date: 01st July,2026 The Secretary, Corporate Relationship Department, The BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400 001 The Company Secretary, National Stock Exchange of India Limited, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai – 400 051 Sub: Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018 for the quarter ended on 30th June, 2026 Ref: BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED (BSE Scrip Code: 524396; ISIN No. : INE829A01014; SCRIP NAME: BIOFILCHEM) Dear Sir/Madam, With reference to the above captioned subject and pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018, please find enclosed herewith the confirmation certificate received from Ankit Consultancy Private Limited, the Registrar and Share Transfer Agent of the Company for the quarter ended on 30th June, 2026. You are requested to please take on record the above said document for your reference and further needful. Thanking you, Yours faithfully, FOR, BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO. A71739 ANKIT CONSULTANCY PVT LTD (REGISTRAR AND SHARE TRANSFER AGENT) 60, ELECTRONIC COMPLEX, PARDESHIPURA, INDORE (MP)-452010 CIN No. : U74140MP1985PTC003074 PHONE NO.: 0731-4065799, 4065797 SEBI REGISTRATION No : INR 000000767 Email: investor@ankitonline.com Website:-www.ankitonline.com S.No. 0 Date -01/07/2026 BIOFIL CHEMICALS & PHARMACEUTICALS LIMITED B/12-B,INDUSTRIAL ESTATE POLOGROUND INDORE MADHYA PRADESH 452015 Subject : Confirmation Certificate in the matter of Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Sir/Madam, We hereby confirm that the securities received from the depository participants for dematerialization during the quarter ended 30 June 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialization have been mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as the registered owner within 15 days. Thanking you, For Ankit Consultancy Pvt.Ltd., CS Saurabh Maheshwari (Compliance officer)